BiotechTube
Home/ETS/Dr. Steven Jung
DS

Dr. Steven Jung

Chief Technology Officer (CTO)

ETS

Therapeutic Areas

Wound CareDiabetic Foot UlcersChronic WoundsSurgical Wounds

ETS Pipeline

DrugIndicationPhase
Mirragen for Diabetic Foot UlcersDiabetic Foot Ulcers (DFUs)Commercial
Mirragen for Other Chronic WoundsVenous Leg Ulcers, Pressure InjuriesResearch/Expansion
Mirragen Genomic ResearchChronic Wound Healing BiomarkersResearch

Leadership Team at ETS

AF
AJ Ford
Chief Executive Officer (CEO)
View full ETS profile